Page last updated: 2024-09-02

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Rupture

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Rupture in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berndt, MC; Bobik, A; Jennings, G; Kannelakis, P; Taylor, AJ1

Other Studies

1 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Rupture

ArticleYear
Serotonin blockade protects against early microvascular constriction following atherosclerotic plaque rupture.
    European journal of pharmacology, 2004, Feb-13, Volume: 486, Issue:1

    Topics: Animals; Arteriosclerosis; Blood Flow Velocity; Disease Models, Animal; Iliac Artery; Indans; Microcirculation; Rabbits; Receptors, Serotonin, 5-HT2; Ritanserin; Rupture; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction

2004